Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 593
Clinical Trials 255
Immune Disorders Drugs 249
Cardiovascular Drugs 209
Drug Discovery 197
Pharmaceuticals 189
Infectious Diseases Drugs 178
Biopharmaceuticals 154
Central Nervous System Drugs 135
Endocrine and Metabolic Disorders Drugs 130
Musculoskeletal Disorders Drugs 112
Liver and Kidney Disorders Drugs 108
Leukemia Drugs 107
Hematological Drugs 100
Lymphoma Drugs 73
Dermatological Drugs 68
Brain Cancer Drugs 66
Skin Cancer Drugs 63
Diabetes Drugs 61
Gastrointestinal Drugs 53
Respiratory Drugs 53
Pharmaceutical Intermediates 48
Lung Cancer Drugs 48
Mental Disorders Drugs 47
Drug Delivery 45
Immunosuppressive Drugs 45
Liver Cancer Drugs 37
Pharmaceutical Manufacturing 37
Bladder Cancer Drugs 35
Analgesics 32
Infusions and Injectables 32
Antibiotics 30
HIV/AIDS Drugs 29
Colon Cancer Drugs 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 24
Prostate Cancer Drugs 23
Cancer Vaccines 23
Schizophrenia Drugs 23
Sexual and Reproductive Health Drugs 21
Ovarian Cancer Drugs 20
Pancreatic Cancer Drugs 20
Urological Disorders Drugs 20
Breast Cancer Drugs 19
Vaccines 18
Cervical Cancer Drugs 17
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 13
Biosimilars and Biosuperiors 13
Anti-Obesity Drugs 11
Generic Drugs 10
Alzheimer's Disease Drugs 9
Company Reports 8
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Uterine Cancer Drugs 7
Anxiety Drugs 5
Addiction Disorders Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



280 reviews

3,134 Results (Page 2 of 157)
- Relevance
  Sort by

Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report

 Report
April 2024
220 Pages
Global

From

€4808EUR$4,950USD£4,147GBP

Global Brain Tumor Therapeutics Market by Type (Glioblastoma, Meningioma, Metastatic Brain Tumors), Therapy (Chemotherapy, Gene Therapy, Immunotherapy), Patient Age Group, Distribution Channel, End-User - Forecast 2024-2030

 Report
March 2024
199 Pages
Global

From

€3277EUR$3,374USD£2,827GBP

€3641EUR$3,749USD£3,141GBP

Blood-Brain Barrier (BBB) Market (2nd Edition), 2020-2030: Focus on Non-Invasive Drug Delivery Technology Platforms and Therapeutics

 Report
March 2020
357 Pages
Global

From

€4758EUR$4,899USD£4,105GBP

Hepatitis C Treatment: Global Strategic Business Report

 Report
April 2024
208 Pages
Global

From

€5293EUR$5,450USD£4,566GBP

Hepatitis Therapeutics - Global Strategic Business Report

 Report
April 2024
94 Pages
Global

From

€5439EUR$5,600USD£4,692GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Global Drug Delivery Across Blood Brain Barrier Market by Drug Delivery Technology (Bispecific Antibody RMT Approach, Passive Diffusion, Permeability Increase of BBB), Application (Alzheimer's Disease, Brain Cancer, Epilepsy) - Forecast 2024-2030

 Report
March 2024
194 Pages
Global

From

€3277EUR$3,374USD£2,827GBP

€3641EUR$3,749USD£3,141GBP

Non-Steroidal Anti-inflammatory Drugs Global Market Report 2024

 Report
February 2024
200 Pages
Global

From

€4856EUR$5,000USD£4,189GBP

Renal cell carcinoma - Pipeline Insight, 2024

 Clinical Trials
April 2024
60 Pages
Global

From

€1943EUR$2,000USD£1,676GBP

Aztreonam Injection Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
January 2024
89 Pages
Global

From

€3500EUR$3,860USD£3,125GBP

Anxiety Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
190 Pages
Global

From

€4759EUR$4,900USD£4,106GBP

Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

 Report
February 2019
105 Pages
Global

From

€1253EUR$1,290USD£1,081GBP

HIV and AIDS Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

 Report
February 2024
87 Pages
Global

From

€3500EUR$3,860USD£3,125GBP

Atopic Dermatitis Drugs - Global Strategic Business Report

 Report
April 2024
179 Pages
Global

From

€4808EUR$4,950USD£4,147GBP

Systemic Lupus Erythematosus (Sle) Drugs - Global Strategic Business Report

 Report
April 2024
184 Pages
Global

From

€4808EUR$4,950USD£4,147GBP

Brain Tumor Drugs Market Forecasts from 2023 to 2028

 Report
November 2023
140 Pages
Global

From

€4322EUR$4,450USD£3,729GBP

Schizophrenia Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

 Report
November 2023
178 Pages
Global

From

€4759EUR$4,900USD£4,106GBP

Melanoma Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

 Report
February 2024
185 Pages
Global

From

€4759EUR$4,900USD£4,106GBP

Organ-based/Targeted Drug Delivery Devices Market for Biologics (Intra-organ / Intra-tumoral), 2020 - 2030

 Report
July 2020
283 Pages
Global

From

€4758EUR$4,899USD£4,105GBP

Systemic Sclerosis (Scleroderma) (Immunology) - Drugs in Development, 2021

 Drug Pipelines
March 2021
Global

From

€2428EUR$2,500USD£2,095GBP

Global Hepatitis Therapeutics Market by Type (Hepatitis A, Hepatitis B, Hepatitis C), Drug Class (Immune Modulator, Oral Antiviral), Distribution Channel - Forecast 2024-2030

 Report
March 2024
199 Pages
Global

From

€3277EUR$3,374USD£2,827GBP

€3641EUR$3,749USD£3,141GBP

3,134 Results (Page 2 of 157)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.